FOR IMMEDIATE RELEASE
February 17, 2016
Ropack Pharma Solutions Appoints Francois Chouinard, Ph.D., Director of Business Development for R&D and Formulation
MONTREAL, CANADA – February 2016 – Ropack Pharma Solutions (RPS), provider of high-quality drug development, manufacturing and packaging of solid oral dosage, has hired Francois Chouinard, Ph.D., as Director of Business Development for R&D and Formulation. Chouinard will report to Paul Dupont, VP, Marketing and Business Development.
Chouinard, who holds a doctorate in Pharmaceutical Sciences, will focus on business development for the drug development facilities in Long Island, New York, purchased by RPS and most recently operated by Forest Labs. “Francois brings a deep understanding of the drug development process,” said Dupont. “His many years of success and experience working in the CDMO/CMO environment, along with his superior customer engagement skills and scientific background, are unique and valuable assets which will advance and support our mission to provide a superior customer engagement experience.”
An internationally experienced Pharma R&D leader, he brings more than 20 years of experience in the generic, contract development and biotech industries, developing more than 30 solid dose products for the Canadian and European markets. Prior to joining RPS, he was Executive Director of Product Development at Halo Pharmaceutical’s Montreal location where he was actively involved in the development of new business opportunities as well as the management of all product development.
“With Ropack Pharma Solutions now providing a complete range of contract development services, my product development experience in brand and generic Pharma will help RPS support the best development strategy for our customers and establish a high level of confidence in our ability to meet their timelines and product quality attributes,” noted Chouinard.
Ropack Pharma Solutions (RPS) supports solid oral dosage projects from early-stage formulation through clinical manufacturing, packaging, distribution and commercial manufacturing and packaging. Facilities in Montreal, Canada, and Long Island, New York, are cGMP-compliant, site-licensed by the FDA and Health Canada-certified.
Like what you read? Share with your network:
VP, Marketing and Business Development, Ropack Pharma Solutions
Email Paul Dupont